CanaQuest Medical Corp. (CANQF)

[NetworkNewsWire]

ADYNF Developing Potential Breakthrough Fortified Formulas to Boost Human Endocannabinoid System

As debates continue over the legalization of marijuana, many individuals who have never touched plant-derived cannabinoids (phytocannabinoids) do not realize that their bodies naturally produce endocannabinoids, which play an essential mediating role in various human physiologic systems. Recent studies have shown that the production of endocannabinoids is boosted by fatty acids, and Algae Dynamics (OTCQB: ADYNF) has begun developing fortified formulas of omega-3s and cannabis oil that could potentially boost the function of the human body’s endocannabinoid system.

“The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae Dynamics’ algae omega-3 oil has a high concentration of DHA, which is in demand by the growing multi-billion dollar food and beverage and health care sectors. The North American omega-3 market was estimated to be $4.0 billion in 2013 and is expected to reach $5.9 billion by 2019, growing at a CAGR of 6.5% from 2014 to 2019. Supplements are the largest application segment driving North America’s omega-3 market, and the cannabinoid market is just as vibrant. It is expected to cross $2 billion in consumer sales by 2020. It seems no matter which market Algae Dynamics chooses for its products, success is almost guaranteed.”

To view the full article, visit http://nnw.fm/rtSN4

About Algae Dynamics

Algae Dynamics is engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. To assist in this development, Algae Dynamics engaged two Canadian universities to provide research, focusing on the use of cannabis oil in the context of cancer and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. Algae Dynamics intends to utilize this research to develop products that combine the significant health benefits of Omega-3 fatty acids derived from algae oil with extracts from cannabis oil for the rapidly growing medical and non-medical markets in Canada and globally. The company has developed strategic relationships with licensed producers of cannabis to ensure a source of cannabis oil. Algae Dynamics’ product development efforts are designed in the near-term for over-the-counter nutraceuticals, and in the longer-term for patented medicines. The company’s recent initiatives are an extension of its previous plan, which was focused solely on commercialization of its proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. For more information, visit the company’s website at http://www.algaedynamics.com.